Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURF-100 for Dry Eye Disease
NCT04734197Phase 2Completed
- Sponsor
- Surface Ophthalmics
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolic acid, betamethasone sodium in dry eye disease (DED), sponsored by Surface Ophthalmics. Started Jan 2021; status: completed.
02
Drugs
mycophenolic acidbetamethasone sodium
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04734197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734197.